Articles published in MedInform are entirely online. There is no printed edition of any published articles.
Each MedInform Journal manuscript is citeable using the date of the manuscript’s first online posting and the Digital Object Identifier (DOI). DOIs are assigned to all SAGE content for use on digital networks; and the metadata associated with that content is registered with the DOI Foundation (www.doi.org). DOIs provide a persistent, permanent way to identify manuscripts published in the online environment.
There are many advantages to publishing with MedInform, some of which are listed below:
- High discoverability
- Rapid publication (within 12 weeks of submission) Authors will have their articles reviewed quickly with fast decision times. Once manuscripts are accepted, articles will enter a speedy, continuous-publication online format
- Rigorous peer review of your research
- Maximum exposure for your research via immediate, worldwide, barrier-free, open access to the full-text of your article — it will be Open Access
- High visibility
- Increased usage
The authors retain copyright under the terms outlined by the Creative Commons Attribution Open Access License Agreement. This license stipulates that anyone is free to copy, distribute, and display the article and derivative works based upon it, provided they give credit to the article. For more information on the Creative Commons Attribution License, please visit http://creativecommons.org/licenses/by/3.0/.
MedInformis managed by Editors-in-Chief Vladimir Panov and Deyan Jelev. They are supported by an international editorial board. Each manuscript submitted to the journal is refereed by a minimum of two reviewers; the Editors-in-Chief then base their final decision on the recommendations of these individuals. The journal operates a single blind peer review policy, in which the reviewer’s names are always concealed from the submitting authors.
MedInform does not yet have an impact factor. As with all publications, SAGE will monitor MedInforml citation activity and will prepare it for submission to the Science Citation Index as soon as possible.
Please direct any inquiries to Dr Miglena Balcheva, Publishing Editor,. Email: [email protected]
You can submit your manuscript, article text file and illustrations, to MedInform as email attachments to [email protected].
………………………
………………………………..
No, all manuscripts must be written in English and submitted exclusively to the Journal of MedInform in order to be considered for publication.
Please direct any inquiries to Dr Miglena Balcheva, Publishing Editor,. Email: [email protected]
As costs are involved in every stage of the publication process, from peer-review, to copy-editing and hosting the final article on dedicated servers, the author is asked to pay an article processing charge.
Payments must be done only after final letter of acceptance of a paper to publication. You will receive an invoice with payment method.
Payment is due within 30 days of receipt of original invoice. Invoices will be chased periodically and a final notice will be issued at 90 days after which the article will be placed under access control, losing its open access status and the debt will be passed to a debt collection agency.
All articles are treated in the same way. They go through the journal’s rigorous process of editorial consideration and peer review, thereby ensuring that the high standards the community has come to expect from the journal are maintained.
Open access papers and subscribed to papers look exactly the same to reviewers and journal editors and so they will be blind to the author’s choice, avoiding any possibility of a conflict of interest during peer review and acceptance.